Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 200 of 226

1.

Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.

Gravesen E, Nordholm A, Mace M, Morevati M, Høgdall E, Nielsen C, Kjær A, Olgaard K, Lewin E.

PLoS One. 2018 Aug 3;13(8):e0201936. doi: 10.1371/journal.pone.0201936. eCollection 2018.

2.

[Novel hormones related to the calcium and phosphate homeostasis in kidney disease].

Mace ML, Ølgaard K, Lewin E.

Ugeskr Laeger. 2018 May 21;180(21). pii: V05170353. Danish.

PMID:
29804564
3.

Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification.

Gravesen E, Lerche Mace M, Nordholm A, Hofman-Bang J, Hruska K, Haagen Nielsen C, Kjær A, Olgaard K, Lewin E.

PLoS One. 2018 Jan 5;13(1):e0190820. doi: 10.1371/journal.pone.0190820. eCollection 2018.

4.

Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.

Nordholm A, Mace ML, Gravesen E, Hofman-Bang J, Morevati M, Olgaard K, Lewin E.

Am J Physiol Renal Physiol. 2018 May 1;314(5):F753-F762. doi: 10.1152/ajprenal.00528.2017. Epub 2017 Nov 29.

PMID:
29187373
5.

Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia.

Mace ML, Gravesen E, Nordholm A, Olgaard K, Lewin E.

Calcif Tissue Int. 2018 Jan;102(1):85-92. doi: 10.1007/s00223-017-0333-9. Epub 2017 Oct 23.

6.

Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.

Mace ML, Gravesen E, Nordholm A, Hofman-Bang J, Secher T, Olgaard K, Lewin E.

Kidney Int. 2017 Jul;92(1):165-178. doi: 10.1016/j.kint.2017.01.015. Epub 2017 Mar 22.

7.

Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Rukov JL, Gravesen E, Mace ML, Hofman-Bang J, Vinther J, Andersen CB, Lewin E, Olgaard K.

Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F477-91. doi: 10.1152/ajprenal.00472.2015. Epub 2016 Jan 6.

8.

Key role of the kidney in the regulation of fibroblast growth factor 23.

Mace ML, Gravesen E, Hofman-Bang J, Olgaard K, Lewin E.

Kidney Int. 2015 Dec;88(6):1304-1313. doi: 10.1038/ki.2015.231. Epub 2015 Jul 29.

PMID:
26221757
9.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
10.

The vascular secret of Klotho.

Lewin E, Olgaard K.

Kidney Int. 2015 Jun;87(6):1089-91. doi: 10.1038/ki.2015.80.

PMID:
26024025
11.

A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+.

Nordholm A, Mace ML, Gravesen E, Olgaard K, Lewin E.

BMC Nephrol. 2015 Mar 15;16:29. doi: 10.1186/s12882-015-0019-3.

12.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

13.

In memoriam: Claus Brun, MD, Dr Med, 1914-2014.

Feldt-Rasmussen B, Brandi L, Olgaard K.

Kidney Int. 2014 Dec;86(6):1069. doi: 10.1038/ki.2014.353. No abstract available.

PMID:
25427078
14.

Claus Brun (1914-2014).

Feldt-Rasmussen B, Brandi L, Olgaard K.

Nephrol Dial Transplant. 2014 Dec;29(12):2348-9. doi: 10.1093/ndt/gfu344. No abstract available.

PMID:
25416822
15.

A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism.

Evenepoel P, Cooper K, Holdaas H, Messa P, Mourad G, Olgaard K, Rutkowski B, Schaefer H, Deng H, Torregrosa JV, Wuthrich RP, Yue S.

Am J Transplant. 2014 Nov;14(11):2545-55. doi: 10.1111/ajt.12911. Epub 2014 Sep 15.

16.

Circulating FGF23 levels in response to acute changes in plasma Ca(2+).

Gravesen E, Mace ML, Hofman-Bang J, Olgaard K, Lewin E.

Calcif Tissue Int. 2014 Jul;95(1):46-53. doi: 10.1007/s00223-014-9861-8. Epub 2014 May 7.

PMID:
24801007
17.

Parathyroid hormone-related peptide plasma concentrations in patients on hemodialysis.

Nordholm A, Rix M, Olgaard K, Lewin E.

Scand J Clin Lab Invest. 2014 Apr;74(3):206-12. doi: 10.3109/00365513.2013.876656. Epub 2014 Jan 23.

PMID:
24456420
18.

High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats.

Gravesen E, Hofman-Bang J, Mace ML, Lewin E, Olgaard K.

BMC Nephrol. 2013 Dec 27;14:281. doi: 10.1186/1471-2369-14-281.

19.

Report on 2012 ISN Nexus symposium: 'Bone and the kidney'.

Drüeke TB, Olgaard K.

Kidney Int. 2013 Apr;83(4):557-62. doi: 10.1038/ki.2012.453. Epub 2013 Jan 16.

20.

Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.

Gravesen E, Hofman-Bang J, Lewin E, Olgaard K.

Scand J Clin Lab Invest. 2013 Mar;73(2):107-16. doi: 10.3109/00365513.2012.744464. Epub 2013 Jan 3.

PMID:
23281842
21.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

22.

Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism.

Hofman-Bang J, Gravesen E, Olgaard K, Lewin E.

Int J Nephrol. 2012;2012:123576. doi: 10.1155/2012/123576. Epub 2012 Oct 10.

23.

Acute macular neuroretinopathy in relation to anti-thymocyte globulin infusion.

Munch IC, Traustason S, Olgaard K, Larsen M.

Acta Ophthalmol. 2012 Jun;90(4):e321-2. doi: 10.1111/j.1755-3768.2011.02276.x. Epub 2011 Oct 19. No abstract available.

24.

Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD.

Olgaard K, Lewin E, Silver J.

Nephrol Dial Transplant. 2011 Apr;26(4):1117-9. doi: 10.1093/ndt/gfq862. Epub 2011 Mar 21. No abstract available.

PMID:
21427074
25.

The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity.

Martuseviciene G, Hofman-Bang J, Clausen T, Olgaard K, Lewin E.

Kidney Int. 2011 Apr;79(7):742-8. doi: 10.1038/ki.2010.501. Epub 2011 Jan 5.

26.

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.

Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R.

Nephrol Dial Transplant. 2010 Dec;25(12):3823-31. doi: 10.1093/ndt/gfq513. Epub 2010 Sep 9. Review.

PMID:
20829401
27.

Increased parathyroid expression of klotho in uremic rats.

Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E.

Kidney Int. 2010 Dec;78(11):1119-27. doi: 10.1038/ki.2010.215. Epub 2010 Jul 14.

28.

Vitamin D controls T cell antigen receptor signaling and activation of human T cells.

von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C.

Nat Immunol. 2010 Apr;11(4):344-9. doi: 10.1038/ni.1851. Epub 2010 Mar 7.

PMID:
20208539
29.

When is Vitamin D contraindicated in dialysis patients?

Lewin E, Olgaard K.

Semin Dial. 2009 May-Jun;22(3):240-2. doi: 10.1111/j.1525-139X.2009.00563.x. Review. No abstract available.

PMID:
19572998
30.

Reply to Dr S.C. Palmer and co-workers.

Olgaard K, Lewin E.

Nephrol Dial Transplant. 2008 Aug;23(8):2709-10. doi: 10.1093/ndt/gfn344. Epub 2008 Jun 13. No abstract available.

PMID:
18556751
32.

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.

Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB.

Atherosclerosis. 2008 Dec;201(2):274-80. doi: 10.1016/j.atherosclerosis.2008.01.015. Epub 2008 Feb 16.

PMID:
18371970
33.

Cardiac structure and function in a mouse model of uraemia without hypertension.

Bro S, Bollano E, Brüel A, Olgaard K, Nielsen LB.

Scand J Clin Lab Invest. 2008;68(7):660-6. doi: 10.1080/00365510802037272.

PMID:
19378440
34.

Abnormal bone and mineral metabolism in kidney transplant patients--a review.

Sprague SM, Belozeroff V, Danese MD, Martin LP, Olgaard K.

Am J Nephrol. 2008;28(2):246-53. Epub 2007 Nov 7. Review.

35.

Can hyperparathyroid bone disease be arrested or reversed?

Olgaard K, Lewin E.

Clin J Am Soc Nephrol. 2006 May;1(3):367-73. Epub 2006 Mar 29. Review.

36.

Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis.

Møller S, Laigaard F, Olgaard K, Hemmingsen C.

Int J Med Sci. 2007 Jul 10;4(4):190-5.

37.

Calcium-sensing receptor and recovery from hypocalcaemia in thyroparathyroidectomized rats.

Huan J, Martuseviciene G, Olgaard K, Lewin E.

Eur J Clin Invest. 2007 Mar;37(3):214-21.

PMID:
17359489
38.

Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.

Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1080-6. Epub 2007 Mar 8.

PMID:
17347482
39.

Influence of parathyroid mass on the regulation of PTH secretion.

Lewin E, Olgaard K.

Kidney Int Suppl. 2006 Jul;(102):S16-21. Review.

PMID:
16810305
40.

Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation.

Lewin E, Olgaard K.

Nephrol Dial Transplant. 2006 Jul;21(7):1766-9. Epub 2006 Jun 8. No abstract available.

PMID:
16762962
41.
42.

Parathyroid growth and suppression in renal failure.

Lewin E, Huan J, Olgaard K.

Semin Dial. 2006 May-Jun;19(3):238-45. Review.

PMID:
16689976
43.

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G; Kidney Disease: Improving Global Outcomes (KDIGO).

Kidney Int. 2006 Jun;69(11):1945-53.

44.

Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia.

Lewin E, Olgaard K.

Nephrol Dial Transplant. 2006 Jul;21(7):1770-2. Epub 2006 Apr 20. Review. No abstract available.

PMID:
16627600
45.

Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.

Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):570-5. Epub 2005 Dec 22.

PMID:
16373611
46.

Impaired kidney growth in low-birth-weight children: distinct effects of maturity and weight for gestational age.

Schmidt IM, Chellakooty M, Boisen KA, Damgaard IN, Mau Kai C, Olgaard K, Main KM.

Kidney Int. 2005 Aug;68(2):731-40.

47.

[Children undergoing chronic hemodialysis. Results from Rigshospitalet, 1991--2002].

Nielsen FT, Olgaard K.

Ugeskr Laeger. 2005 Feb 28;167(9):1041-5. Danish. No abstract available.

PMID:
15804002
48.
49.

Increased kidney growth in formula-fed versus breast-fed healthy infants.

Schmidt IM, Damgaard IN, Boisen KA, Mau C, Chellakooty M, Olgaard K, Main KM.

Pediatr Nephrol. 2004 Oct;19(10):1137-44. Epub 2004 Aug 11.

PMID:
15309602
50.

Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats.

Lange M, Qvortrup K, Svendsen OL, Flyvbjerg A, Nowak J, Petersen MM, ØLgaard K, Feldt-Rasmussen U.

Bone. 2004 Jul;35(1):178-85.

PMID:
15207754
51.

Kidney growth in 717 healthy children aged 0-18 months: a longitudinal cohort study.

Schmidt IM, Main KM, Damgaard IN, Mau C, Haavisto AM, Chellakooty M, Boisen KA, Petersen JH, Scheike T, Olgaard K.

Pediatr Nephrol. 2004 Sep;19(9):992-1003. Epub 2004 Jun 17.

PMID:
15206038
52.

Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.

Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB.

J Am Soc Nephrol. 2004 Jun;15(6):1495-503.

53.

Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.

Rix M, Eskildsen P, Olgaard K.

Nephrol Dial Transplant. 2004 Apr;19(4):870-6.

PMID:
15031343
54.

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L; Bone Turnover Work Group.

Am J Kidney Dis. 2004 Mar;43(3):558-65. Review. No abstract available.

PMID:
14981615
55.

Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.

Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB.

J Am Soc Nephrol. 2003 Oct;14(10):2466-74.

56.

Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.

Lewin E, Garfia B, Almaden Y, Rodriguez M, Olgaard K.

Kidney Int. 2003 Jul;64(1):63-70.

57.

[Calcimimetics and secondary uremic hyperparathyroidism. The Danish Society of Nephrology].

Ølgaard K.

Ugeskr Laeger. 2003 Mar 17;165(12):1245. Danish. No abstract available.

PMID:
12701295
58.

Role of calcitonin in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in the rat.

Wang W, Lewin E, Olgaard K.

Eur J Clin Invest. 2002 Sep;32(9):674-81.

PMID:
12486867
59.

Rate-dependency of calcitonin secretion in response to increased plasma Ca2+.

Wang W, Lewin E, Olgaard K.

Eur J Clin Invest. 2002 Sep;32(9):669-73.

PMID:
12486866
60.

Separate effects of 1,25-dihydroxyvitamin D and calcium on renal calbindin-D28k and intestinal calbindin-D9k.

Hemmingsen C, Staun M, Nielsen PK, Olgaard K.

Pharmacol Toxicol. 2002 Sep;91(3):111-5.

PMID:
12427110
62.

Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal failure--a report on linear growth and adverse effects.

Hertel NT, Holmberg C, Rönnholm KA, Jacobsen BB, Olgaard K, Meeuwisse GW, Rix M, Pedersen FB.

J Pediatr Endocrinol Metab. 2002 May;15(5):577-88.

PMID:
12014516
63.

Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men.

Brandi L, Egfjord M, Olgaard K.

Nephrol Dial Transplant. 2002 May;17(5):829-42.

PMID:
11981071
64.

Dual energy X-ray absorptiometry in small rats with low bone mineral density.

Petersen MM, Nielsen PK, Lewin E, Olgaard K.

Calcif Tissue Int. 2000 Dec;67(6):455-9.

PMID:
11289694
65.

Prevention of uremic bone disease using calcimimetic compounds.

Olgaard K, Lewin E.

Annu Rev Med. 2001;52:203-20. Review.

PMID:
11160775
66.

PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.

Lewin E, Almaden Y, Rodriguez M, Olgaard K.

Kidney Int. 2000 Jul;58(1):71-81.

67.
68.

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.

Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K.

Kidney Int. 1999 Sep;56(3):1084-93.

69.

The plasma leptin concentration is closely associated with the body fat mass in nondiabetic uremic patients.

Clausen P, Nielsen PK, Olgaard K, Feldt-Rasmussen B.

Am J Nephrol. 1999;19(4):485-91.

PMID:
10460939
70.

Calciotropic hormones and the skeleton in uraemia.

Lewin E, Olgaard K.

Eur J Clin Invest. 1999 Jun;29(6):466-8. Review. No abstract available.

PMID:
10354206
71.
72.
74.

Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize?

Bro S, Brandi L, Daugaard H, Olgaard K.

Perit Dial Int. 1997 Nov-Dec;17(6):554-9. Review.

PMID:
9655154
75.

The effect of 1,25-vitamin D3 on calbindin-D and calcium-metabolic variables in the rat.

Hemmingsen C, Staun M, Olgaard K.

Pharmacol Toxicol. 1998 Mar;82(3):118-21.

PMID:
9553988
76.

Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis.

Bro S, Rasmussen RA, Handberg J, Olgaard K, Feldt-Rasmussen B.

Am J Kidney Dis. 1998 Feb;31(2):257-62.

PMID:
9469496
77.

Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients.

Clausen P, Feldt-Rasmussen B, Jacobsen P, Rossing K, Parving HH, Nielsen PK, Feldt-Rasmussen U, Olgaard K.

Diabet Med. 1997 Dec;14(12):1038-43.

PMID:
9455931
78.

PTH--one can teach an old hormone new tricks.

Bro S, Olgaard K.

Nephrol Dial Transplant. 1997 Nov;12(11):2222-4. No abstract available.

PMID:
9394302
79.

Effects of excess PTH on nonclassical target organs.

Bro S, Olgaard K.

Am J Kidney Dis. 1997 Nov;30(5):606-20. Review.

PMID:
9370175
80.

Reversibility of experimental secondary hyperparathyroidism.

Lewin E, Wang W, Olgaard K.

Kidney Int. 1997 Nov;52(5):1232-41.

81.

Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA.

Nielsen PK, Rasmussen AK, Butters R, Feldt-Rasmussen U, Bendtzen K, Diaz R, Brown EM, Olgaard K.

Biochem Biophys Res Commun. 1997 Sep 29;238(3):880-5.

PMID:
9325185
82.
83.

Urinary calcium excretion and renal calbindin-D28k.

Hemmingsen C, Staun M, Meibom K, Bang K, Olgaard K.

Kidney Blood Press Res. 1997;20(4):247-50.

84.

How to evaluate hypercalcaemia in the patient with chronic renal failure.

Olgaard K.

Nephrol Dial Transplant. 1996 Dec;11(12):2509-12. No abstract available.

PMID:
9017637
85.

Effect of vitamin D metabolites and analogs on renal and intestinal calbindin-D in the rat.

Hemmingsen C, Staun M, Lewin E, Nielsen PK, Olgaard K.

Calcif Tissue Int. 1996 Nov;59(5):371-6.

PMID:
8849404
86.

Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro.

Nielsen PK, Rasmussen AK, Feldt-Rasmussen U, Brandt M, Christensen L, Olgaard K.

J Clin Endocrinol Metab. 1996 Oct;81(10):3793-6.

PMID:
8855839
87.

A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells.

Nielsen PK, Feldt-Rasmussen U, Olgaard K.

Nephrol Dial Transplant. 1996 Sep;11(9):1762-8.

PMID:
8918619
89.

Effect of parathyroid hormone on renal calbindin-D28k.

Hemmingsen C, Staun M, Lewin E, Nielsen PK, Olgaard K.

J Bone Miner Res. 1996 Aug;11(8):1086-93.

PMID:
8854244
90.

[Evaluation and treatment of patients with kidney calculi].

Daugaard H, Kristensen JK, Olgaard K.

Ugeskr Laeger. 1996 Apr 29;158(18):2521-5. Review. Danish.

PMID:
8686003
91.

Intermittent intravenous followed by intermittent oral 1 alpha(OH)D3 treatment of secondary hyperparathyroidism in uraemia.

Brandi L, Daugaard H, Egsmose C, Tvedegaard E, Kjaerulff Nielsen P, Olgaard K.

J Intern Med. 1996 Apr;239(4):353-60.

PMID:
8774390
92.
93.

Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.

Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.

Nephron. 1996;74(1):89-103. Erratum in: Nephron 1997;77(3):353.

PMID:
8883025
94.
95.

Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period.

Jakobsen BK, Ryder LP, Ladefoged J, Løkkegaard H, Nielsen B, Olgaard K, Svejgaard A.

Transplant Proc. 1995 Dec;27(6):3452-3. No abstract available.

PMID:
8540048
96.

Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.

Wahlberg J, Wilczek HE, Fauchald P, Nordal KP, Heaf JG, Olgaard K, Hansen JM, Lokkegaard H, Mueller EA, Kovarik JM.

Transplantation. 1995 Oct 15;60(7):648-52.

PMID:
7570970
97.

The calcium/parathyroid hormone concept of the parathyroid glands.

Lewin E, Nielsen PK, Olgaard K.

Curr Opin Nephrol Hypertens. 1995 Jul;4(4):324-33. Review.

PMID:
7552098
98.

Regulation of renal calbindin-D28K: the role of calcitonin.

Hemmingsen C, Staun M, Lewin E, Olgaard K.

Calcif Tissue Int. 1995 May;56(5):372-5.

PMID:
7621344
99.

Comparison of straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: a prospective randomized study.

Nielsen PK, Hemmingsen C, Friis SU, Ladefoged J, Olgaard K.

Perit Dial Int. 1995;15(1):18-21.

PMID:
7734555
100.

Calcium metabolic changes and calbindin-D in experimental hypertension.

Hemmingsen C, Staun M, Lewin E, Egfjord M, Olgaard K.

J Hypertens. 1994 Aug;12(8):901-7.

PMID:
7814849
101.

Metabolism of intact PTH by isolated perfused kidney and liver from uremic rats.

Daugaard H, Egfjord M, Lewin E, Olgaard K.

Exp Nephrol. 1994 Jul-Aug;2(4):240-8.

PMID:
8069660
102.

Metabolism of N-terminal and C-terminal parathyroid hormone fragments by isolated perfused rat kidney and liver.

Daugaard H, Egfjord M, Lewin E, Olgaard K.

Endocrinology. 1994 Mar;134(3):1373-81.

PMID:
8119177
104.

A consecutive study of 646 peritoneal dialysis catheters.

Nielsen PK, Hemmingsen C, Ladefoged J, Olgaard K.

Perit Dial Int. 1994;14(2):170-2. No abstract available.

PMID:
8043673
106.

PD-related infections of standard and different disconnect systems.

Tofte-Jensen P, Klem S, Nielsen PK, Olgaard K.

Adv Perit Dial. 1994;10:214-7.

PMID:
7999831
107.

Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone.

Olgaard K, Lewin E, Bro S, Daugaard H, Egfjord M, Pless V.

Miner Electrolyte Metab. 1994;20(5):309-14.

PMID:
7700220
108.

Effects of magnesium on renal and intestinal calbindin-D.

Hemmingsen C, Staun M, Olgaard K.

Miner Electrolyte Metab. 1994;20(5):265-73.

PMID:
7700214
109.

Parathyroid hormone dependent T cell proliferation in uremic rats.

Lewin E, Ladefoged J, Brandi L, Olgaard K.

Kidney Int. 1993 Aug;44(2):379-84.

110.

Effect of uremia on aldosterone metabolism in the isolated perfused rat liver.

Egfjord M, Daugaard H, Olgaard K.

Metabolism. 1993 Apr;42(4):470-6.

PMID:
8487670
111.

Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation.

Christiansen E, Andersen HB, Rasmussen K, Christensen NJ, Olgaard K, Kirkegaard P, Tronier B, Vølund A, Damsbo P, Burcharth F, et al.

Am J Physiol. 1993 Mar;264(3 Pt 1):E441-9.

PMID:
8460692
112.

Metabolism of prednisone in kidney transplanted patients with necrosis of the femoral head.

Lausten GS, Egfjord M, Olgaard K.

Pharmacol Toxicol. 1993 Feb;72(2):78-83.

PMID:
8474968
113.

A model of reversible uremia employing isogenic kidney transplantation in the rat. Reversibility of secondary hyperparathyroidism.

Lewin E, Colstrup H, Pless V, Ladefoged J, Olgaard K.

Scand J Urol Nephrol. 1993;27(1):115-20.

PMID:
8493458
114.

Effects of methylprednisolone and uremia on renal and intestinal calbindin-D in the rat.

Egfjord M, Staun M, Olgaard K.

Clin Chim Acta. 1992 Nov 16;212(1-2):47-54.

PMID:
1486681
115.

[Cyclosporin A treatment of adult patients with severe nephrotic syndrome].

Nyrop M, Olgaard K.

Ugeskr Laeger. 1992 Jul 6;154(28):1944-8. Danish.

PMID:
1509556
116.
117.
118.

Aldosterone metabolism in the isolated perfused liver of R and S hypertension-prone Dahl rats.

Egfjord M, Olgaard K.

Am J Physiol. 1992 Apr;262(4 Pt 1):E488-96.

PMID:
1566837
119.

Steroid-induced mandibular bone loss in relation to marginal periodontal changes.

von Wowern N, Klausen B, Olgaard K.

J Clin Periodontol. 1992 Mar;19(3):182-6.

PMID:
1556246
120.

The impact of repeated HLA mismatches on the outcome of renal allograft retransplantation.

Povlsen JV, Madsen M, Birkeland SA, Løkkegaard H, Pedersen EB, Svejgaard A, Olgaard K, Fjeldborg O.

Transplant Proc. 1992 Feb;24(1):307-8. No abstract available.

PMID:
1539288
121.

Long-term suppression of secondary hyperparathyroidism by intravenous 1 alpha-hydroxyvitamin D3 in patients on chronic hemodialysis.

Brandi L, Daugaard H, Tvedegaard E, Nielsen PK, Egsmose C, Storm T, Olgaard K.

Am J Nephrol. 1992;12(5):311-8.

PMID:
1488999
122.

[The significance of brain death as a criterion for renal transplantation. Status after 9 months].

Rasmussen K, Colstrup H, Kristensen JK, Ladefoged J, Olgaard K.

Ugeskr Laeger. 1991 Sep 30;153(40):2831-2. Danish.

PMID:
1926619
123.

Renal and intestinal calcium-binding proteins in normal and uraemic rats.

Staun M, Egfjord M, Daugaard H, Olgaard K.

Scand J Clin Lab Invest. 1991 Apr;51(2):111-8.

PMID:
2042015
124.

Aldosterone metabolism in combined isolated perfused rat liver and kidney.

Egfjord M, Daugaard H, Olgaard K.

Am J Physiol. 1991 Apr;260(4 Pt 2):F536-48. Erratum in: Am J Physiol 1991 Dec;261(6 Pt 3):following Index. Am J Physiol 1991 Sep;261(3 Pt 2):following Table of Contents.

PMID:
2012206
125.

Metabolism of parathyroid hormone in isolated perfused rat kidney and liver combined.

Daugaard H, Egfjord M, Olgaard K.

Kidney Int. 1990 Jul;38(1):55-62.

126.

Influence of calcium on the metabolism of intact parathyroid hormone by isolated perfused rat kidney and liver.

Daugaard H, Egfjord M, Olgaard K.

Endocrinology. 1990 Apr;126(4):1813-20.

PMID:
2318144
127.
128.

Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.

Tvedegaard E, Olgaard K.

Transplant Proc. 1990 Feb;22(1):217-8. No abstract available.

PMID:
2106738
129.

Cyclosporin A treatment of severe steroid resistant nephrotic syndrome in adults.

Nyrop M, Olgaard K.

J Intern Med. 1990 Jan;227(1):65-8.

PMID:
2299300
130.

Aldosterone metabolism in the isolated perfused liver of female and male rats.

Egfjord M, Olgaard K.

Endocrinology. 1989 Dec;125(6):3011-21.

PMID:
2583053
131.

[Simultaneous transplantation of the pancreas and kidney in terminal diabetic nephropathies].

Burcharth F, Rasmussen K, Kirkegaard P, Olgaard K.

Ugeskr Laeger. 1989 Feb 27;151(9):544-7. Danish.

PMID:
2646799
132.
133.

Necrosis of the femoral head after renal transplantation.

Lausten GS, Jensen JS, Olgaard K.

Acta Orthop Scand. 1988 Dec;59(6):650-4.

PMID:
3063055
134.

Hypovolemic stimuli and vasopressin secretion in man.

Hammer M, Olgaard K, Schapira A, Bredgaard Sørensen M, Jensen K, Bonde-Petersen F.

Acta Endocrinol (Copenh). 1988 Aug;118(4):465-73.

PMID:
3400402
135.

Metabolism of intact parathyroid hormone in isolated perfused rat liver and kidney.

Daugaard H, Egfjord M, Olgaard K.

Am J Physiol. 1988 Jun;254(6 Pt 1):E740-8.

PMID:
3377074
136.

Plasma exchange after revascularization compartment syndrome with acute toxic nephropathy caused by rhabdomyolysis.

Paaske WP, Bagl P, Lorentzen JE, Olgaard K.

J Vasc Surg. 1988 Jun;7(6):757-8.

PMID:
3373616
137.

Plasma free and sulfoconjugated dopamine in man: relationship to sympathetic activity, adrenal function and meals.

Eldrup E, Hagen C, Christensen NJ, Olgaard K.

Dan Med Bull. 1988 Jun;35(3):291-4.

PMID:
3168558
138.

The effect of cyclosporine A on the hepatic clearance rate of prednisone in isolated perfused livers of normal and uremic rats.

Egfjord M, Daugaard H, Olgaard K.

Transplant Proc. 1988 Apr;20(2 Suppl 2):549-52. No abstract available.

PMID:
3363654
139.

Bone mineral content by photon absorptiometry of the mandible compared with that of the forearm and the lumbar spine.

von Wowern N, Storm TL, Olgaard K.

Calcif Tissue Int. 1988 Mar;42(3):157-61.

PMID:
3130164
140.

Isolated perfused rat kidney and liver combined. A new experimental model.

Daugaard H, Egfjord M, Olgaard K.

Pflugers Arch. 1987 Jun;409(1-2):220-2.

PMID:
3615169
141.

[Chronic dialysis in children. Results from the Danish National Hospital 1970-1984].

Ladefoged J, Madsen S, Olgaard K.

Ugeskr Laeger. 1987 Jan 19;149(4):211-4. Danish. No abstract available.

PMID:
3547973
142.

Increased clearance rate of prednisone in the isolated perfused liver of uremic rats.

Egfjord W, Langhoff E, Daugaard H, Olgaard K.

Nephron. 1987;45(1):53-8.

PMID:
3808150
143.

The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures.

Langhoff E, Olgaard K, Ladefoged J.

Int J Immunopharmacol. 1987;9(4):469-73.

PMID:
3497887
144.

An abnormal response of the adrenal cortex to insulin: glucose in essential hypertension.

Olgaard K, Tvedegaard E, Langhoff E, Hammer M, Madsen S, Daugaard H, Egfjord M, Ladefoged J.

J Clin Hypertens. 1986 Dec;2(4):354-9.

PMID:
3543229
145.
146.

Pregnancy following kidney transplantation.

Marushak A, Weber T, Bock J, Birkeland SA, Hansen HE, Klebe J, Kristoffersen K, Rasmussen K, Olgaard K.

Acta Obstet Gynecol Scand. 1986;65(6):557-9.

PMID:
3541482
147.

Differential biological effects of calcitonin and parathyroid hormone on isolated perfused bone.

Arbelaez M, Olgaard K, Schwartz J, Martin K, Klahr S, Slatopolsky E.

Miner Electrolyte Metab. 1986;12(2):92-7.

PMID:
3007966
148.

Sodium homeostasis after small-bowel resection.

Ladefoged K, Olgaard K.

Scand J Gastroenterol. 1985 Apr;20(3):361-9.

PMID:
3890141
149.

Clinical results and cyclosporine effect on prednisolone metabolism of cadaver kidney transplanted patients.

Langhoff E, Madsen S, Olgaard K, Ladefoged J.

Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:963-8.

PMID:
3887391
150.

Aldosterone response to modulation of potassium in patients on dialysis or with essential hypertension.

Olgaard K, Langhoff E, Tvedegaard E, Madsen S, Hammer M, Daugaard H, Egfjord M, Ladefoged J.

Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:815-9.

PMID:
3887382
151.

Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients.

Langhoff E, Madsen S, Flachs H, Olgaard K, Ladefoged J, Hvidberg EF.

Transplantation. 1985 Jan;39(1):107-9. No abstract available.

PMID:
3880958
152.

Impaired skeletal response to parathyroid hormone in uremia: the role of phosphorus.

Olgaard K, Schwartz J, Arbelaez M, Slatopolsky E.

Contrib Nephrol. 1985;49:32-7. No abstract available.

PMID:
2420528
153.

Some microbiological aspects of inedible rendering processes.

Hansen PI, Olgaard K.

Zentralbl Bakteriol Mikrobiol Hyg B. 1984 Dec;180(1):3-20.

PMID:
6441385
154.

Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.

Olgaard K, Finco D, Schwartz J, Arbelaez M, Teitelbaum S, Avioli L, Klahr S, Slatopolsky E.

Kidney Int. 1984 Dec;26(6):791-7.

155.

[Clinical results of immunosuppression with cyclosporin A in cadaveric kidney transplantation].

Madsen S, Kristensen JK, Langhoff E, Olgaard K, Ladefoged J, Thaysen JH.

Ugeskr Laeger. 1984 Mar 26;146(13):951-4. Danish. No abstract available.

PMID:
6372185
156.

The impact of HLA-DR compatibility on cadaver kidney graft survival in a prospective study with special emphasis on the quality of typing.

Jakobsen BK, Langhoff E, Platz P, Ryder LP, Thaysen JH, Olgaard K, Kristensen JK, Jørgensen HE, Løkkegaard H, Rasmussen F, et al.

Tissue Antigens. 1984 Feb;23(2):94-103.

PMID:
6369628
157.

Number and distribution of bacteria on some beef carcasses at selected abattoirs in some member states of the European communities.

Roberts TA, Hudson WR, Whelehan OP, Simonsen B, Olgaard K, Labots H, Snijders JM, Van Hoof J, Debevere J, Dempster JF, Devereux J, Leistner L, Gehra H, Gledel J, Fournaud J.

Meat Sci. 1984;11(3):191-205. doi: 10.1016/0309-1740(84)90037-8.

PMID:
22054857
158.

Altered adenosine 3',5'-monophosphate release in response to parathyroid hormone by isolated perfused bone from glucocorticoid-treated dogs.

Korkor A, Martin KJ, Olgaard K, Bergfeld M, Teitelbaum S, Klahr S, Slatopolsky E.

Endocrinology. 1983 Aug;113(2):625-31.

PMID:
6191963
159.

Lack of influence of 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion from normal or hyperplastic glands.

Rothstein M, Olgaard K, Arbelaez M, Finco D, Klahr S, Slatopolsky E.

Calcif Tissue Int. 1983 Jul;35(4-5):449-54.

PMID:
6604566
160.

Extraction of parathyroid hormone and release of adenosine 3',5'-monophosphate by isolated perfused bones obtained from dogs with acute uremia.

Olgaard K, Schwartz J, Finco D, Arbelaez M, Korkor A, Martin K, Klahr S, Slatopolsky E.

Endocrinology. 1982 Nov;111(5):1678-82. No abstract available.

PMID:
6290194
161.

Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.

Olgaard K, Arbelaez M, Schwartz J, Klahr S, Slatopolsky E.

Calcif Tissue Int. 1982 Jul;34(4):403-7.

PMID:
6291732
162.

Extraction of vitamin D metabolites by bones of normal adult dogs.

Olgaard K, Schwartz J, Finco D, Arbelaez M, Haddad J, Avioli L, Klahr S, Slatopolsky E.

J Clin Invest. 1982 Mar;69(3):684-90.

163.

Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure.

Madsen S, Olgaard K, Ladefoged J.

J Clin Endocrinol Metab. 1981 Oct;53(4):823-7.

PMID:
6895227
164.

Two cases of 17 alpha-hydroxylase deficiency--one combined with complete gonadal agenesis.

Tvedegaard E, Frederiksen V, Olgaard K, Nielsen MD, Starup J.

Acta Endocrinol (Copenh). 1981 Oct;98(2):267-73.

PMID:
6270940
165.

Computer modelling of aldosterone regulation in patients on regular hemodialysis.

Olgaard K, Ladefoged J, Madsen S.

Int J Biomed Comput. 1981 May;12(3):205-15.

PMID:
7251214
166.

Calcium-stimulated vasopressin secretion in uremic patients: an effect mediated via parathyroid hormone?

Hammer M, Ladefoged J, Madsen S, Olgaard K, Tvedegaard E.

J Clin Endocrinol Metab. 1980 Nov;51(5):1078-84.

PMID:
7419683
167.

The inability of angiotensin II infusions to raise plasma vasopressin levels in haemodialysis patients.

Hammer M, Olgaard K, Madsen S.

Acta Endocrinol (Copenh). 1980 Nov;95(3):422-6.

PMID:
7001833
168.

Relationship between plasma osmolality and plasma vasopressin in human subjects.

Hammer M, Ladefoged J, Olgaard K.

Am J Physiol. 1980 Apr;238(4):E313-7.

PMID:
7377293
169.

Plasma aldosterone regulation in anephric and non-nephrectomized patients on regular haemodialysis. A survey.

Olgaard K.

Dan Med Bull. 1980 Feb;27(1):22-35. Review. No abstract available.

PMID:
6249547
170.

Pathogenesis of hypophosphatemia in kidney necrograft recipients: a controlled trial.

Olgaard K, Madsen S, Lund B, Lund B, Sørensen OH.

Adv Exp Med Biol. 1980;128:255-61. No abstract available.

PMID:
6999856
171.

Direct feed-back regulation of PTH-secretion by 1,25-dihydroxyvitamin D3 in renal failure: a controlled trial.

Madsen S, Olgaard K, Ladefoged J.

Proc Eur Dial Transplant Assoc. 1980;17:557-62.

PMID:
6894641
172.

Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure.

Olgaard K, Madsen S, Heerfordt J, Hammer M, Jensen H.

Clin Nephrol. 1979 Dec;12(6):273-8.

PMID:
527281
173.

Influence of age on the endocrine-metabolic response to surgery.

Blichert-Toft M, Christensen V, Engquist A, Fog-Moller F, Kehlet H, Madsen SN, Skovsted L, Thode J, Olgaard K.

Ann Surg. 1979 Dec;190(6):761-70.

174.

Epidural analgesia inhibits the renin and aldosterone response to surgery.

Brandt MR, Olgaard K, Kehlet H.

Acta Anaesthesiol Scand. 1979 Jun;23(3):267-72.

PMID:
484183
175.

Thyrotropin-releasing-hormone tests.

Kirkegaard C, Olgaard K, Faber J, Siersbaek-Nielsen K, Friis T.

Lancet. 1979 Mar 10;1(8115):556. No abstract available.

PMID:
85141
176.

[Drug information. Etalpha].

Madsen S, Olgaard K.

Ugeskr Laeger. 1979 Jan 29;141(5):310-2. Danish. No abstract available.

PMID:
760313
177.

Aldosterone in myxoedema.

Olgaard K, Borup K.

Lancet. 1979 Jan 27;1(8109):218. No abstract available.

PMID:
84243
178.

Pathogenesis of hypophosphataemia in kidney necrograft recipients: a controlled trial.

Madsen S, Olgaard K, Lund B, Lund B, Sørensen OH.

Proc Eur Dial Transplant Assoc. 1979;16:618-23. No abstract available.

PMID:
398522
179.

Hormonal response to volume depletion in non-nephrectomised patients on regular haemodialysis.

Hammer M, Dawids S, Sørensen MB, Christensen O, Olgaard K.

Proc Eur Dial Transplant Assoc. 1979;16:252-60.

PMID:
398494
180.
181.

[Radioimmunological determination of plasma aldosterone].

Olgaard K, Madsen S, Ladefoged J.

Ugeskr Laeger. 1978 May 15;140(20):1151-4. Danish. No abstract available.

PMID:
664055
182.

Calcium-dependent aldosterone secretion in anephric and nonnephrectomized patients on regular hemodialysis.

Olgaard K, Madsen S, Hammer M, Ladefoged J.

J Clin Endocrinol Metab. 1978 May;46(5):740-6.

PMID:
233632
183.

[Measurements of ionized calcium in whole blood and serum. An evaluation of a recently developed analyzer].

Madsen S, Olgaard K, Ladefoged J.

Ugeskr Laeger. 1978 Apr 3;140(14):774-7. Danish. No abstract available.

PMID:
25502
184.

Inhibition of aldosterone response to surgery by saline administration.

Engquist A, Blichert-Toft M, Olgaard K, Brandt MR, Kehlet H.

Br J Surg. 1978 Apr;65(4):224-7.

PMID:
638442
185.

Degree and course of skeletal demineralization in patients with chronic renal insufficiency.

Madsen S, Olgaard K, Ladefoged J.

Scand J Urol Nephrol. 1978;12(3):243-9. No abstract available.

PMID:
725546
187.

Bone mineral content in chronic renal failure during long-term treatment with 1alpha-hydroxycholecalciferol.

Madsen S, Olgaard K, Ladefoged J.

Acta Med Scand. 1978;203(5):385-9. No abstract available.

PMID:
665304
188.

Osteoscintigraphic changes in kidney-transplanted patients.

Heerfordt J, Olgaard K, Madsen S, Vistisen L, Jensen H, Løokkegaard H, Brix E.

Nephron. 1978;21(2):86-94. No abstract available.

PMID:
353575
189.

Cessation of bone loss in chronic renal failure by 1-alpha-hydroxyvitamin D3: a controlled trial.

Madsen S, Olgaard K, Ladefoged J.

Proc Eur Dial Transplant Assoc. 1978;15:517-23.

PMID:
311003
190.

The effect of 1alpha-hydroxyvitamin D3 in patients with chronic renal failure, with particular emphasis on the renal handling of phosphate.

Madsen S, Olgaard K.

Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:85s-89s. No abstract available.

PMID:
606430
191.

Circadian rhythm of plasma aldosterone and plasma renin activity in steroid and non-steroid treated kidney transplanted patients.

Olgaard K, Madsen S, Roosen J, Hammer M.

Scand J Clin Lab Invest. 1977 Sep;37(5):431-7.

PMID:
337462
192.

[Plasma renin activity as determinated using a kit].

Olgaard K, Ladefoged J.

Ugeskr Laeger. 1977 Jul 4;139(27):1590-2. Danish. No abstract available.

PMID:
561466
193.
194.

Determination of relative bacterial levels on carcasses and meats-a new quick method.

Olgaard K.

J Appl Bacteriol. 1977 Jun;42(3):321-9. No abstract available.

PMID:
328473
195.

Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.

Olgaard K, Madsen S, Ladefoged J, Regeur L.

Eur J Clin Invest. 1977 Feb;7(1):61-6.

PMID:
402278
196.

The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.

Madsen S, Olgaard K, Ladefoged J.

Adv Exp Med Biol. 1977;81:141-8.

PMID:
899923
197.
198.
199.

Is renal osteodystrophy reversible?

Madsen S, Thaysen JH, Olgaard K, Heerfordt J, Løkkegaard H.

Proc Eur Dial Transplant Assoc. 1977;14:433-41.

PMID:
341142
200.

Supplemental Content

Loading ...
Support Center